Rajeev Raghu, OD
Optometrist · Jackson, NJNPI 1467503748
Payments from drug & device makers
Across 29 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$147
- Coopervision Inc.$122
- AstraZeneca$91
- Bausch & Lomb, A Division Of Bausch Health US, LLC$36
- Visioneering Technologies, Inc.$34
- Bausch & Lomb Americas Inc.$33
- plus $129 from 6 others
What the payments were for
- Food & beverage$594100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 6 | $147 |
| Coopervision Inc. | 6 | $122 |
| AstraZeneca | 1 | $91 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $36 |
| Visioneering Technologies, Inc. | 4 | $34 |
| Bausch & Lomb Americas Inc. | 1 | $33 |
| AbbVie(2 entities) | 2 | $28 |
| Menicon America Inc | 2 | $28 |
| Quidel Corporation | 1 | $25 |
| Maculogix, Inc. | 1 | $20 |
| ABB Con-cise Optical Group LLC | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
How this compares
$594 in reported general payments places this provider in the 45th percentile of 1,357 optometrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RocklatanNetarsudil Mesylat/Latanoprost | 12 | $6,763 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 30 | $2,203 |
| Latanoprost | 121 | $1,644 |
| Timolol Maleate | 38 | $596 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $395 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 27 | $253 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Jackson
- Kerry GelbWoodbridge$264K
- Rodolfo RodriguezNorth Bergen$244K
- Steven SorkinFairfield$146K
- Paul VaccarellaRockaway$99K
- Ada NohCinnaminson$74K
- Kristen FryTeaneck$66K
- Melanne RosettaIselin$66K
- Frank BuccieroSpringfield$57K
- Debbie EdegranCloster$53K
- Victoria DzurinkoDeptford$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.